IMRX and Immuneering's Class B, compared from Immuneering's SEC filings. Each fact links the filing it comes from.
The class record does not settle Class B's economic rights against IMRX's.
Each IMRX share has one vote.
Each Class B share has no vote.
The class record does not settle whether any of these classes can be converted into another.
On October 23, 2026 there were 64,763,155 IMRX shares outstanding.
Source: Cover of imrx-20260930.htm, filed October 29, 2026 · 0001790340-26-000097
Class B's shares outstanding are not on the latest cover in the class record.
Every sentence is built from the reviewed class record, not written by hand; a new filing updates it.
Loading...